Additionally, in vitro studies reported that tumour cells can produce endogenous fibrinogen and the combination of FGF-2 and fibrinogen can stimulate the proliferation of endothelial cells, leading to enhanced angiogenesis [38,39]. The gene discussed is FGF2; the disease is neoplasm.